Lipid peroxidation in neurodegeneration: New insights into Alzheimer's disease

Current Opinion in Lipidology

Volumn 13, Issue 3, 2002, Pages 289-294

  Arlt, Sönke ^a   Beisiegel, Ulrike ^a   Kontush, Anatol ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; AMYLOID BETA PROTEIN; CHELATING AGENT; LIPID; METAL DERIVATIVE; NEUROPROTECTIVE AGENT; ANTIOXIDANT; METAL;

ALZHEIMER DISEASE; BODY FLUID; CELL DAMAGE; CEREBROSPINAL FLUID ANALYSIS; CHELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; METAL BINDING; NERVE DEGENERATION; NEUROPATHOLOGY; OXIDATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; ANIMAL; BRAIN; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMAL; ANTIOXIDANTS; BRAIN; HUMAN; LIPID PEROXIDATION; METALS; NERVE DEGENERATION; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS;

EID: 0035985698     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200206000-00009     Document Type: Review

References (61)

1. Low density lipoprotein oxidation and its pathobiological significance
2. Pathophysiology of oxidative stress in diabetes mellitus
3. Chemistry and biochemistry of oxidative stress in neurodegenerative disease
4. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin
5. Acrolein inhibits respiration in isolated brain mitochondria
6. The isoprostanes: Their quantification as an index of oxidant stress status in vivo
7. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance
8. Continuous monitoring of in vitro oxidation of human low density lipoprotein
9. Current status of acrolein as a lipid peroxidation product
10. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures
11. Time-course of oxidation of lipids in human cerebrospinal fluid in vitro
12. Metals and neuroscience
13. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
14. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
15. Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo
16. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
17. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures
18. Oxidative stress in Alzheimer's disease
19. Nascent astrocyte particles differ from lipoproteins in CSF
20. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid
21. Characterization of four lipoprotein classes in human cerebrospinal fluid
22. Ascorbate regulation and its neuroprotective role in the brain
23. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo
24. Increased lipoprotein oxidation in Alzheimer's disease
25. Increased CSF F2-isoprostane concentration in probable AD
26. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease
27. Are isoprostanes a clinical marker for antioxidant drug investigation?
28. Oxidized low-density lipoprotein induces neuronal death: Implications for calcium, reactive oxygen species, and caspases
29. Amyloid β-peptide is produced by cultured cells during normal metabolism
30. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells
31. Alzheimer's soluble amyloid β protein is secreted by HepG2 cells as an apolipoprotein
32. Redox-active iron mediates amyloid-β toxicity
33. Characterization of copper interactions with alzheimer amyloid β peptides: Identification of an attomolar-affinity copper binding site on amyloid β1-42
34. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion
35. The A β peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
36. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
37. Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-β content
38. Oxidative damage is the earliest event in Alzheimer disease
39. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis
40. Mercury induces cell cytotoxicity and oxidative stress and increases β-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells
41. Oxidative stress increases production of β-amyloid precursor protein and β-amyloid (Aβ) in mammalian lenses, and Aβ has toxic effects on lens epithelial cells
42. Does human βA4 exert a protective function against oxidative stress in Alzheimer's disease?
43. Mitochondrial free radical generation, oxidative stress, and aging
44. Oxidative stress, antioxidants, and Alzheimer disease
45. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
46. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease
47. Intramuscular desferrioxamine in patients with Alzheimer's disease
48. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
49. Treatment of Alzheimer's disease with clioquinol
50. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
51. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease
52. Brain iron pathways and their relevance to Parkinson's disease
53. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients
54. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients
55. Copper and prion disease
56. Prion disease: A loss of antioxidant function?
57. Imbalance of antioxidant defense in mice lacking cellular prion protein
58. Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities
59. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies
60. Creutzfeldt-Jakob disease and oxidative stress
61. Amyloid-β: An antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease